CJC-1295 and Ipamorelin are commonly discussed together because they represent two different upstream signals into the growth hormone axis
(B) Semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of uncoupling protein 1 (UCP1), mitochondrial biosynthesis, and thermogenic marker, or promote fatty browning through nitric oxide synthase (NOS), neuropeptides (NPs), sirtuin 1 (STRT1), signal transducer and activator of transcription 3 (STAT3), and bone morphogenetic protein 4 (BMP4) signaling
10.1016/j.biochi.2010.06.009 62 KimK.PortisJ
Most people begin to see weight loss within four to eight weeks after reaching their target dose, which might take several weeks due to gradual dose increases
It usually subsides as the body adjusts to the medication